GLP-1 drugs have been linked to increased risk of gallbladder disease , and they carry warnings about possible associations with pancreatitis
This is also the window where you can genuinely assess whether the medication is working for you
however, they release toxic compounds, such as myeloperoxidase, which triggers additional production of reactive oxygen species, cytokines, and neutrophil extracellular traps (NETs), further aggravating the disease setting and progression [23]
If you were to buy into the marketing hype around GLP-1 drugs like Wegovy and Zepbound, you might believe they are a panacea for every patient who needs to lose weight, regardless of BMI
Wellness isnt simply about losing weight or having energy
Secondly, there is the influence of the underlying disease status and combined medication